PHARMA DANCKAERT
ActivePHARMA DANCKAERT has been active since 1978 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €35k and a net result of €-8k. Equity is shrinking by ~13.8% per year across the filed fiscal years. Its solvency ranks better than 37% of 10252 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (low).
Checked score
Score 2025
43
/ 100
Weak
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability11▲+11
Solvency51▼-12
Growth32=
Track record100
Bankruptcy probability, 12 months
0.5%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €1k at 30 days only on tighter terms
Liquidity tight (current ratio 1.32 against 1.55 in 2024; short-term debt: 73.6% of total assets), and 73.6% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
26.4%
Return on assets
-6.4%
Age of the figures
9 mo
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025Net result per financial year
1819202122232425
2018 to 2025 · latest year €-8k
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-06-2026, 52 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
52 d early
2024
14 d early
2023
28 d early
2022
32 d early
2021
31 d early
2020
25 d early
2019
30 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
17-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€35k▼ 19.5%
2024 · €43k
2018: €99k
2019: €105k
2020: €106k
2021: €97k
2022: €78k
2023: €63k
2024: €43k
2018 → 2025
Total assets
€132k▲ 15.3%
2024 · €115k
2018: €181k
2019: €136k
2020: €151k
2021: €128k
2022: €125k
2023: €115k
2024: €115k
2018 → 2025
Net result
€-8k▲ 57.8%
2024 · €-20k
2018: €-5k
2019: €6k
2020: €323
2021: €-9k
2022: €-18k
2023: €-15k
2024: €-20k
2018 → 2025
Working capital
€31k▼ 20.8%
2024 · €40k
2018: €95k
2019: €97k
2020: €96k
2021: €89k
2022: €70k
2023: €58k
2024: €40k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€97k-€78k▼ 18.9%€63k▼ 19.2%€43k▼ 31.7%€35k▼ 19.5%
Operating result€-2k-€-11k▼ 441%€-9k▲ 23.1%€-14k▼ 53.9%€-2k▲ 84.7%
Net result€-9k-€-18k▼ 104%€-15k▲ 17.6%€-20k▼ 33.1%€-8k▲ 57.8%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €2k in 2025 against €14k in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €132k
Fixed assets
€4k▼ 5.9%
Current assets
€129k▲ 16.0%
Equity and liabilities €132k
Equity
€35k▼ 19.5%
Debt
€97k▲ 36.4%
The debt ratio rises from 62.2% to 73.6%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€-1k▲
2024 · €-11k
Cash flow
€-8k▲
2024 · €-18k
Solvency
26.4%▼
2024 · 37.8%
Current ratio
1.32▼
2024 · 1.55
Quick ratio
0.78▼
2024 · 0.90
Debt / equity
2.79▲
2024 · 1.65
ROE
-24.3%▲
2024 · -46.3%
ROA
-6.4%▲
2024 · -17.5%
Interest coverage
-0.22▲
2024 · -1.70
Debt
€97k▲
2024 · €71k
Debt ≤ 1 year
€97k▲
2024 · €71k
Staff costs
€71k▲
2024 · €64k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€115k€132k▲
Fixed assets21/28€4k€4k▼
Tangible fixed assets22/27€4k€4k▼
Plant, machinery and equipment23€4k€4k▼
Current assets29/58€111k€129k▲
Stocks and contracts in progress3€47k€53k▲
Stocks30/36€47k€53k▲
Amounts receivable within one year40/41€60k€71k▲
Trade receivables40€35k€33k▼
Other amounts receivable41€26k€38k▲
Deferred charges and accrued income490/1€4k€5k▲
Equity and liabilities
Total equity and liabilities10/49€115k€132k▲
Equity10/15€43k€35k▼
Contributions10/11€50k€50k=
Reserves13€7k€7k=
Non-distributable reserves130/1€6k€6k=
Reserves not available under the articles1311€6k€6k=
Tax-exempt reserves132€1k€1k=
Profit (loss) carried forward14€-14k€-23k▼
Amounts payable17/49€71k€97k▲
Amounts payable within one year42/48€71k€97k▲
Financial debts43€8k€13k▲
Credit institutions430/8€8k€13k▲
Trade debts44€32k€20k▼
Suppliers440/4€32k€20k▼
Taxes, remuneration and social security45€2k€2k▼
Taxes450/3€2k€2k▼
Other amounts payable47/48€29k€63k▲
Income statement
Code20242025
Remuneration, social security and pensions62€64k€71k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2k€690▼
Other operating charges640/8€382€408▲
Gross operating margin9900€54k€70k▲
Operating profit (loss)9901€-14k€-2k▲
Financial income75/76B€24€5▼
Recurring financial income75€24€5▼
Financial charges65/66B€7k€6k▼
Recurring financial charges65€7k€6k▼
Profit (loss) for the period before taxes9903€-20k€-8k▲
Profit (loss) for the period9904€-20k€-8k▲
Profit (loss) for the period to be appropriated9905€-20k€-8k▲
Appropriation of the result
Profit (loss) to be appropriated9906€-14k€-23k▼
Profit (loss) brought forward from the previous period14P€6k€-14k▼
Social balance
Average headcount (FTE)90870.80.8=
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
09-06
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
17-07
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Weakest financial yearnet €-20k
Net result drops to €-20k, the lowest in the series; recovery starts the following year.
03-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
29-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
30-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
06-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
01-07
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
31-12
Financial
Back to profitnet €6k
Net result €6k after one loss-making year.
31-12
Financial
Equity above €100kEq €105k ▲6.2%
Equity rises from €99k to €105k.
22-05
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
04-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
28-06
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Antwerpen · 1 establishment unit since 1978
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Ter Heydelaan 1732100 AntwerpenGround area
366 m²
Building footprint
208 m²
Volume, LiDAR
2,914 m³
Parcel 11343A0569/00N003, Flanders · tallest building 17.3 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
Ter Heydelaan 173, 2100 Antwerpen
since 19782.108.499.292
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11343A0569/00N003 | Flanders | 366 m² | 1 · 208 m² | 17.3 m · 5 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteAntwerpen2.108.499.292
Similar companies · same sector, comparable size
Apotheek Huys-Van Hecke
BE 0885.737.286
Hasselt · Eq €35k
Katrien Smets
BE 0779.830.213
Heist-op-den-Berg · Eq €35k
LAB 06
BE 1003.651.872
Ecaussinnes · Eq €35k
DEPOUHON SPRLU
BE 0554.918.687
Chastre · Eq €35k
PHARMACIE HERMAN GEOFFREY
BE 0474.463.721
Andenne · Eq €35k
Of 5,224 companies in sector 47730 we hold annual accounts for 3,864. 2,238 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company (pre-2019)
Founded19-04-1978
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 48 filingsAddress and cadastre registers
Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryPhone:03/3249530